YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
STAMFORD, Conn., July 08, 2026 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating potential legal claims on behalf of stockholders of Estrella Immunopharma, Inc. (“Estrella”). This investigation is to determine whether Estrella’s boar…
EMERYVILLE, Calif., March 23, 2026--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) ("Estrella" or the "Company"), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to…
By David Bautz, PhD NASDAQ: ESLA READ THE FULL ESLA RESEARCH REPORT Initiating Coverage We are initiating coverage of Estrella Immunopharma (NASDAQ: ESLA) with a valuation of $12.00 per share and a thesis centered on the potential for the…
One thing I like about Barchart’s Top 100 Stocks to Buy list is that it reminds me that stocks are expensive relative to historical norms. However, there’s still a lot of optimism that stocks will continue to rally into 2026 -- the S&P 500…
* Estrella Immunopharma (NASDAQ:ESLA [https://seekingalpha.com/symbol/ESLA]) entered into a securities purchase agreement for a private investment in public equity financing, expected to raise ~$3.35M in gross proceeds. * The company will…
The International Monetary Fund believes that most of the impact from tighter money policies has already affected the U.S. economy, with the rest expected this year. Despite worries about a recession, the U.S. has shown resilience and stro…